NAS:IBB
iShares Biotechnology ETF | |
| $ 189.76 0.25 ( +0.13%) 04:00 PM EST | |
PE Ratio:
22.41
PB Ratio:
4.94
Volume:
2.14M
Dividend Yield %:
0.22
| |
| Last Holding update 2026-07-13 | 246 Stocks (1 new) |
| Value $8.11 Bil | Turnover 4 % |
Registrant: iShares Biotechnology ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
7 /10
Profitability Rank
5 /10
GF Value Rank
6 /10
Growth Rank
8 /10
Momentum Rank
4 /10
iShares Biotechnology ETF Geographic Breakdown
iShares Biotechnology ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
iShares Biotechnology ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 187.65 | ||
| Day's Range ($) | 187.15 - 191.38 | ||
| Day's Volume | 2,143,481 | ||
| 52-Week Range ($) | 128.84 - 199.05 | ||
| Beta | 0.6865 | ||
| 3-Year Sharpe Ratio | 0.61 | ||
| 3-Year Sortino Ratio | 1.05 | ||
| Volatility | 16.3 | ||
| 14-Day RSI | 58.34 | ||
| 14-Day ATR ($) | 3.66214 | ||
| 20-Day SMA ($) | 187.872 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 9,241.312 | ||
| Shares Outstanding (Mil) | 48.7 | ||
| PE Ratio | 22.41 | ||
| PE Ratio (10y Range) | 12.7 - 74.16 | ||
| PE Ratio (10y Median) | 21.3 | ||
| PB Ratio | 4.94 | ||
| PB Ratio (10y Range) | 1.69 - 7.5 | ||
| PB Ratio (10y Median) | 4.79 |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | 0.412 | ||
| Dividend Yield % | 0.22 | ||
| Dividend Yield % (10y Range) | 0.12 - 0.45 | ||
| Dividend Yield % (10y Median) | 0.26 | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
IBB iShares Biotechnology ETF Fundamental Charts
Historical TTM Price-to-Earnings for IBB iShares Biotechnology ETF
Historical TTM Price-to-Earnings without NRI for IBB iShares Biotechnology ETF
Historical Price-to-Book Ratio for IBB iShares Biotechnology ETF
Historical Dividend Yields for IBB iShares Biotechnology ETF
iShares Biotechnology ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with NAS:IBB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IBB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iShares Biotechnology ETF Top Holdings of 2026-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 4,515,707 | 629,354.1 | -17.66% | 7.760 | -1.43% | 0.360 | -1.80% | +10.75% | 166,718.0 | Drug Manufacturers | |
AMGN | Amgen Inc | 1,733,148 | 609,808.1 | -13.24% | 7.520 | -1.04% | 0.320 | +3.87% | +13.54% | 197,689.7 | Drug Manufacturers | |
VRTX | Vertex Pharmaceuticals Inc | 1,354,033 | 604,629.9 | -14.93% | 7.450 | -1.29% | 0.530 | +10.07% | +7.12% | 123,260.6 | Biotechnology | |
REGN | Regeneron Pharmaceuticals Inc | 758,232 | 585,840.4 | +1.65% | 7.220 | +0.12% | 0.720 | -9.71% | -12.09% | 70,943.5 | Biotechnology | |
ALNY | Alnylam Pharmaceuticals Inc | 979,642 | 324,134.2 | +2.42% | 4.000 | +0.09% | 0.730 | -13.62% | -32.74% | 35,710.6 | Biotechnology | |
INSM | Insmed Inc | 1,587,887 | 259,651.3 | +2.43% | 3.200 | +0.08% | 0.730 | -25.03% | -37.76% | 23,478.6 | Biotechnology | |
ARGX | argenx SE | 341,883 | 249,660.1 | +14.59% | 3.080 | +0.39% | 0.550 | +1.40% | +2.38% | 53,575.9 | Biotechnology | |
BIIB | Biogen Inc | 1,091,046 | 200,021.5 | +1.07% | 2.470 | +0.03% | 0.740 | +16.15% | +17.05% | 30,411.8 | Drug Manufacturers | |
NTRA | Natera Inc | 980,622 | 196,114.6 | +1.29% | 2.420 | +0.03% | 0.680 | +30.23% | +18.46% | 38,867.2 | Medical Diagnostics & Research | |
UTHR | United Therapeutics Corp | 315,509 | 187,090.5 | +3.05% | 2.310 | +0.07% | 0.740 | -8.96% | +9.94% | 22,737.0 | Drug Manufacturers |
iShares Biotechnology ETF's Historical Top Holdings Breakdowns
iShares Biotechnology ETF's Top Stock Picks
View Full List
| Ticker |
|---|
GILD |
VRTX |
AMGN |
| RNAM Unlock Delisted |
| ASND Unlock Delisted |
ARGX |
| DVAX Unlock Delisted |
ROIV |
REGN |
MIRM |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 2026-03-31 | Reduce Reduce | -1.43% | 118.3 ($140.04) 155.8 | $134.28 | -4.11% | Reduce -17.66% | 4,515,707 | -968,529 | |
VRTX | Vertex Pharmaceuticals Inc | 2026-03-31 | Reduce Reduce | -1.29% | 433.07 ($466.29) 499.17 | $485.65 | 4.15% | Reduce -14.93% | 1,354,033 | -237,573 | |
AMGN | Amgen Inc | 2026-03-31 | Reduce Reduce | -1.04% | 320.72 ($356.5) 388.16 | $366.29 | 2.75% | Reduce -13.24% | 1,733,148 | -264,583 | |
| RNAM Unlock Delisted | Avidity Biosciences Inc | 2026-03-31 | Sold Out Sold Out | -0.88% | 70.63 ($71.2) 71.47 | $71.34 | 0.20% | Sold Out | 0 | -1,018,024 | |
| ASND Unlock Delisted | Ascendis Pharma AS | 2026-03-31 | Sold Out Sold Out | -0.87% | 202.99 ($224.17) 242.09 | $244.26 | 8.96% | Sold Out | 0 | -341,419 | |
ARGX | argenx SE | 2026-03-31 | Add Add | +0.39% | 663.93 ($782.53) 864.42 | $860.94 | 10.02% | Add 14.59% | 341,883 | 43,533 | |
| DVAX Unlock Delisted | Dynavax Technologies Corp | 2026-03-31 | Sold Out Sold Out | -0.16% | 15.38 ($15.52) 15.72 | $15.50 | -0.13% | Sold Out | 0 | -861,108 | |
ROIV | Roivant Sciences Ltd | 2026-03-31 | Add Add | +0.15% | 21.14 ($25.69) 29.72 | $34.52 | 34.39% | Add 14.22% | 3,642,557 | 453,349 | |
REGN | Regeneron Pharmaceuticals Inc | 2026-03-31 | Add Add | +0.12% | 732.87 ($765.59) 812.27 | $676.69 | -11.61% | Add 1.65% | 758,232 | 12,321 | |
MIRM | Mirum Pharmaceuticals Inc | 2026-03-31 | Add Add | +0.10% | 75.56 ($94.07) 108.62 | $118.75 | 26.24% | Add 27.03% | 392,677 | 83,559 |
iShares Biotechnology ETF Total Holding History ($B)
iShares Biotechnology ETF's Asset Allocation
iShares Biotechnology ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
iShares Biotechnology ETF's Hypothetical Growth since 2026-03-31
iShares Biotechnology ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
iShares Biotechnology ETF's Holdings Heat Map
Size field: